CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company
Phio Pharmaceuticals Corp.
Sign in to watch- Ticker
- PHIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453215903
- Phone
- (508) 767-3861
- Business address
- 411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
- Former names
- RXi Pharmaceuticals Corp
- Open-market buys, last 90 days
- $104,806
- in 9 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$104,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | Deming David H Director | Purchase | +5,200 | $0.84 | $4K | 49,800 |
| 2026-11-10 | Deming David H Director | Purchase | +6,800 | $0.84 | $6K | 44,600 |
| 2026-11-09 | Plott Ronald Todd Director | Purchase | +18,300 | $0.83 | $15K | 60,300 |
| 2026-11-09 | Bitterman Robert J Chairman, Pres. & CEO | Purchase | +25,000 | $0.82 | $21K | 789,871 |
| 2026-09-29 | Plott Ronald Todd Director | Purchase | +5,000 | $1.04 | $5K | 42,000 |
| 2026-09-28 | Plott Ronald Todd Director | Purchase | +5,000 | $1.03 | $5K | 37,000 |
| 2026-09-28 | Bitterman Robert J Chairman, Pres. & CEO | Grant or award | +400,000 | 764,871 | ||
| 2026-09-28 | Plott Ronald Todd Director | Grant or award | +17,000 | 32,000 | ||
| 2026-09-28 | Carson Lisa Cabott Chief Financial Officer | Grant or award | +108,000 | 189,112 | ||
| 2026-09-24 | BRADFORD PATRICIA A Director | Purchase | +6,500 | $1.01 | $7K | 64,151 |
| 2026-09-22 | Bitterman Robert J Chairman, Pres. & CEO | Purchase | +2,000 | $1.03 | $2K | 364,871 |
| 2026-09-15 | BRADFORD PATRICIA A Director | Purchase | +12,000 | $1.03 | $12K | 57,651 |
| 2026-09-11 | Bitterman Robert J Chairman, Pres. & CEO | Shares withheld for taxes | −68,550 | $1.03 | $71K | 362,871 |
| 2026-09-11 | Carson Lisa Cabott Chief Financial Officer | Shares withheld for taxes | −12,888 | $1.03 | $13K | 81,112 |
| 2026-08-19 | Plott Ronald Todd Director | Purchase | +15,000 | $1.14 | $17K | 15,000 |
| 2026-08-18 | Bitterman Robert J Chairman, Pres. & CEO | Purchase | +10,000 | $1.06 | $11K | 431,421 |
| 2026-06-26 | Bitterman Robert J Chairman, Pres. & CEO | Purchase | +10,000 | $0.99 | $10K | 421,421 |
| 2026-02-05 | Lockshin Curtis Director | Grant or award | +16,600 | 35,155 | ||
| 2026-02-05 | Freeman Jonathan E Director | Grant or award | +16,600 | 32,655 | ||
| 2026-02-05 | Deming David H Director | Grant or award | +23,800 | 37,800 |
Page 1 of 6 · 112 trades